header logo image


Page 516«..1020..515516517518..530540..»

Can the coronavirus really affect sufferers’ eyes, as Dominic Cummings claimed? – The Irish News

June 6th, 2020 7:45 am

BRITISH Prime Minister Boris Johnson's chief adviser Dominic Cummings last week claimed he had travelled with his family to Barnard Castle in County Durham "to see if I could drive safely". His explanation was that he had thought his vision might have been affected by coronavirus.

Eye symptoms are recognised as a possible symptom of the disease conjunctivitis, sticky eyes and red eyes have been reported in around a third of patients according to a small study in Wuhan, China, published in March.

Conjunctivitis is also included as a less common symptom in the World Health Organisation's official list. But could Covid-19 affect vision? Robert MacLaren, a professor of ophthalmology at Oxford University, says: "You would be expected to make a full recovery from the eye problems reported so far, although it may cause temporary difficulties such as blurred vision."

The Royal National Institute Of Blind People says: "There is no evidence of sight loss caused directly by the virus," but noted "research is being carried out into some very rare cases that appear to be secondary to other complications such as blood clots caused by the virus".

Solo dmg media

Link:
Can the coronavirus really affect sufferers' eyes, as Dominic Cummings claimed? - The Irish News

Read More...

Retinal artery occlusion related to atherosclerosis | | thetandd.com – The Times and Democrat

June 6th, 2020 7:45 am

Dear Doctor: A friend of our family suddenly lost the vision in his left eye because of something called retinal artery occlusion. What is that? How do you protect against it?

Dear Reader: To answer your question, we should begin with a bit of anatomy. The retina is a layer of light-sensitive tissue that lines the back of the eye. Its job is to receive the incoming rays of light that pass through the lens and translate them into signals. These signals, or impulses, then travel along the optic nerve to the brain, which interprets them as the images we see. As with all tissues within the body, the retina needs a steady supply of blood to function properly. In the case of the retina, this comes primarily from an artery and a vein. If either of these vessels, or any of their smaller branches, become blocked, which is known as an occlusion, the retina sustains damage.

When a blockage occurs in the vein that serves the retina, the blood can't drain away. Instead, it backs up and raises pressure within the eye, which can cause serious damage that affects sight. When the blockage occurs in the artery, as with your family friend, the retina is starved of oxygen and nutrients. Unless blood flow is restored quickly, the blockage will cause the cells of the retina to die. The result is a loss of vision. Unfortunately, there is no way to reverse the damage that arises as a result of retinal vessel occlusion.

Originally posted here:
Retinal artery occlusion related to atherosclerosis | | thetandd.com - The Times and Democrat

Read More...

Granddad has sight saved by opticians at Specsavers – Warrington Guardian

June 6th, 2020 7:45 am

A GRANDDAD has had his sight saved thanks to opticians and surgeons.

Robert Scott, from Paddington, woke up one morning last month with a shadow on the bottom of his right eye.

At the urging of his wife Anne, the 63-year-old made an appointment at Specsavers on Sankey Street in the town centre where he was examined by optometrist Andrea Eaton.

She said: "I spoke to Robert initially on the phone to assess the situation and invited him into the store for a thorough examination later that day.

"Although closed for routine appointments, we have remained open for those requiring immediate attention while following government advice on social distancing and hygiene.

"It was clear upon close inspection that Roberts retina had detached from its position, becoming separated from the blood supply that provides it with essential nutrients and oxygen.

"I referred him immediately to the St Pauls Eye Unit at the Royal Liverpool University Hospital."

Retired company director Robert underwent surgery to reattach the retina the next day in order to save his sight.

The dad-of-two and granddad-of-four is now recovering at home after a successful operation.

He said: "When the shadow in my vision first appeared, I went to bed and thought nothing of it.

"It was only when I mentioned it to my wife the next day that I was compelled to get it looked at.

I had no idea it could be so serious.

"Id encourage anyone else experiencing unusual symptoms to get checked out straight away.

"Thanks to Andreas quick action in-store at Specsavers and the talented surgeons that worked on me, my sight will eventually return.

"For that Im very grateful."

Continue reading here:
Granddad has sight saved by opticians at Specsavers - Warrington Guardian

Read More...

Lets Appreciate The Athletes Who Managed To Make Rec Specs Look Cooler Than They Have Any Right To Be – BroBible

June 6th, 2020 7:45 am

Ive been watching a lot of NASCAR lately, primarily because its the only sport that has gotten everything up and running again with any sort of regularity. That isnt to say things are back to normal, because with no fans and everyone at the track wearing masks, its clear we still have a while to go.

However, during a recent race, something unusual and completely unrelated to safety measures caught my eye (a pun, as youll soon see, could not have been more intended).

While looking at Joey Loganos in-car camera, I noticed he was wearing what appeared to be a pair of run-of-the-mill prescription glasses beneath his helmet. This stuck with me for two reasons because A) I would have thought driving a racecar would be more of a contact lens situation and B) it was an inspiring example of an athlete with less-than-great eyesight making it work.

I grew up with lousy eyes. If I had a pair of billiard balls in my eye sockets, my vision would only be marginally worse than it is now. At a certain point, I was forced to don a pair of glasses and endure the common barrage of childhood taunts that come with them, like four eyes and Look at this guy with his glasses! What do you do? Read books or something? Ha!

Fortunately for me and other people with vision issues, there have been heroic athletes who broke barriers by wearing glasses where no glasses had been worn before (or where its at least fairly inconvenient).

Lets take a look at some of the sports worlds bespectacled heroes.

When I was playing Little League and swinging at every ball that came my way (and several other flying objects I thought were baseballs but turned out not to be), I thought my hopes of making it to The Show were dashed. Damn you, feeble eyes. Damn you!

However, proof that poor eyesight was not a baseball career death sentence would come by way of the Great White North. Enter: Eric Gagne.

Best remembered as a closer for the Los Angeles Dodgers (where he was an absolute save machine), Gagne also brought some serious specs to the mound. They looked like theyd be at home at the shooting range just as much as they did on the mound.

Imagine having to come to the plate in the ninth down by two. The entire game rests on your shoulders. Youre shaking in your cleats as it is, and now, youre getting the stare down from those glasses. Youd swing at anything just to retreat into the clubhouse and drink a beer.

While pitching ability is probably the main reason Gagne was able to become the fastest pitcher to reach 100 saves, I like to think the glasses helped a little bit.

Folks, its important to remember that there are other eye maladies than just not seeing clearly. Thats why Kareem Abdul-Jabbar, the NBAs all-time leading scorer, opted to throw on his iconic goggles in the first place. Due in part to his height, Kareem got poked in the eyes a lot, and back in his college days, he even missed two games with a cornea injury.

Everyone knows you cant rack up copious amounts of points if youre sitting on the bench or missing an eye thanks to a defenders rogue finger. Youve got to protect those peepers, and if that means goggles, you wear goggles.

Abdul-Jabbar was a member of the Milwaukee Bucks and the Los Angeles Lakers during his career, but yknow what? He was also a Trailblazer.for eye protection.

Even the gridiron has seen some glasses and (with apologies to Rodrigo Blankenship) there is perhaps no case more notable thanLos Angeles Rams running back Eric Dickerson.

Dickerson sported a pair of rec specs during his time in the league, even if it was a less than desirable necessity. In a 2016 interview on the NFL Network, Dickerson was asked if his trademark frames were prescription or all style, to which he responded:

I am blind as a bat. I hated them goggles. I hated wearing those goggles.

I tried to go without them a couple times. Id go through practice and put contacts in. They worked. Id get into the game. I said, Keep my goggles on the sideline. First hit, contacts pop out.

Whether he was a fan of his eyewear or not, they helped Dickerson become a Pro Football Hall of Famer, and if there was an Athletic Eyewear Hall of Fame (which Im now realizing should be in Los Angles because that seems to be where everyone with glasses played at some point) hed be a first-ballot inductee there too.

No, notthoseHanson Brothers. Were talking about another group of long-haired siblings who played together 20 years before MMMBop dominated the charts: Jack, Steve, and Jeff Hanson, who were scoffed at for their numerous eccentricities from the moment they arrived in Charleston, West Virginia in Slap Shot.

They were mocked for beating up a soda machine that had the audacity to take their quarter, playing slot cars in their hotel room on a road trip, and, of course, for all wearing thick-rimmed, Buddy Holly-esque glasses.

But the second the three got the nod from Chiefs player-coach Reggie Dunlop in a game against the Broome County Blades, the trio took the entire Federal League by storm, dismantling the opposition and even squaring up against the likes of Tim Dr. Hook McCracken and the fearsome Ogie Oglethorpe.

The Hansons are some of the greatest inspirations in the history of corrective athletic optometry. It could be even be argued by some that their presence helped to keep the Chiefs from relocating to Florida.

The Hanson Brothers: absolute legends of both the rink and the optometrists office.

Read more here:
Lets Appreciate The Athletes Who Managed To Make Rec Specs Look Cooler Than They Have Any Right To Be - BroBible

Read More...

VERIFY: Is it safe to wear contacts to a protest or can tear gas cause blindness? – WUSA9.com

June 6th, 2020 7:44 am

The Verify team looked into online rumors that toxic fumes like tear gas can cause blindness if people wear contacts. Our experts say this is false.

Can toxic fumes like tear gas cause blindness if people are wearing contacts?

No. Contacts could soak in the fumes, or act as a reservoir for these fumes, which could cause increased pain and possible damage if kept on the eye for a long period of time. However, there is no evidence that it could cause blindness.

Dr. Lyndon Jones, Centre For Ocular Research and Education at the University of Waterloo.

Dr. Ravi Goel, American Academy of Ophthalmology

After a week of protests, over the killing of George Floyd in Minneapolis, there have been a number of social media rumors popping up as a result. Some on social media have started to make a pretty dramatic claim about the effects of tear gas.

"Do not wear contacts to any protest," wrote one person on Twitter. "When exposed with tear gas, your contacts will burn and glue to your eye, causing you to become permanently blind."

The claim is certainly enough to scare those who might be heading to a protest.

To find the truth, the Verify team reached out to Dr. Lyndon Jones, The Director of the Centre for Ocular Research and Education at the University of Waterloo.

He addressed the rumor head-on.

"Contact lenses dont get glued to your eye," he said. "Thats actually physically impossible. Theres always a layer of tears behind the lens. It might feel thats the case because its so excruciatingly painful."

Jones explained that there are different types of gas that might be used at a protest. Tear gas, which is man-made, is likely the most well-known of the substances, but it's not the only one being used.

During Washington, D.C. protests, reporter Nathan Baca found a canister, labeled as "Oleoresins Capiscum," or OC for short. Johnson said that this is a scientific name for pepper spray, which is a natural substance.

"Pepper Spray, the oil-based one, could potentially be soaked up by the contact lens and then be held against the eye," Johnson said. "So that might make a difference."

Dr. Ravi Goel, the Spokesperson for the American Academy of Ophthalmology, agreed, saying that these lenses could act as a "reservoir," holding in the fumes. He said that contact lenses can cause serious damage, if left in for a long period of time, after tear gas is released.

"It can be a liability," he said. "If there's a gas or physical trauma."

So we can verify, wearing contacts when hit with tear bad will not cause blindness. However, it could keep the fumes in your eye longer and cause more irritation.

For that reason, it might be a good idea to bring goggles to cover your eyes, or simply wear glasses, if there's a chance of facing these fumes.

See original here:
VERIFY: Is it safe to wear contacts to a protest or can tear gas cause blindness? - WUSA9.com

Read More...

How billions of tiny gold flecks could help restore vision and treat blindness – inews

June 6th, 2020 7:44 am

NewsHealthGold 'nanobars' absorb heat of near-infrared light helping to repair damaged retina cells

Thursday, 4th June 2020, 7:00 pm

They are hopeful that their technique could be available on the health service within a decade although they caution that much more work is needed to determine the process is safe and effective first.

Experiments on mice showed the new technique effectively restored sight in mice with macular degeneration, a leading cause of blindness.

It will now be tested on humans in a huge clinical trial.

Golden Eye

We are very excited indeed by our findings, said Daniel Hillier, of the German Primate Center in Gttingen.

"We believe that near-infrared stimulation is an important step towards providing useful vision to blind patients so that they can regain their ability to read or see faces", said Dr Hillier.

The technique involves implanting billions of gold miniscule nanobars into the retina. These capture near-infrared light rays, absorbing their heat and slowly releasing it into the eye.

The heat makes the damaged photoreceptors vibrate and that movement helps them bind with functional genes delivered to the retina at the same time through a separate injection - and sight is restored.

Hope for blind people

"We want to give hope to blind people with these findings and will further intensify our research activities in this area. We have also demonstrated this method in cultured human retinas [in the lab], so the next step is clinical trials, said Dr Hillier.

The good thing is that the core component [the delivery system for the functional genes] is already approved for clinical use. Therefore I expect the human trials to be relatively straightforward, he said.

Macular degeneration is one of the major reasons for visual impairment, with nearly 200 million people affected worldwide. Photoreceptors in the retina are responsible for capturing the light. Diseased photoreceptors lose their sensitivity to light, which can lead to impaired vision or even complete blindness.

The study is published in the journal Science.

Original post:
How billions of tiny gold flecks could help restore vision and treat blindness - inews

Read More...

Profiteers on the prowl as mass blindness is loosed upon us all – The East African

June 6th, 2020 7:44 am

By JENERALI ULIMWENGUMore by this Author

A motorist suddenly stops in the midst of a rush-hour traffic jam and starts flailing his arms before his face in obvious panic. Then another driver, then another, then another.

The traffic jam is building behind the first commuter, until somebody from the long line behind the first character moves over to the car causing all the blockage, and discovers in horror that the man they have all been hooting at is blind as an owl, and is totally helpless.

This is the beginning of Blindness, a superb novel by Portuguese winner of the Nobel award for literature, Jose Saramago, now sadly passed, a novel that frequently reminds me of how a sudden affliction can change the way we behave with ourselves and with each other.

In Blindness it soon becomes clear that nearly everyone in that town (no name places, no country, no people names, no dates, no season) is going blind, and in a short time a new order is established where practically everyone is blind, and a new hierarchy and social order establishes itself along the lines of the limitations imposed by the mass blindness.

But this is society, and it shall, perforce, be social; this means it has to adapt to the new realities of sightlessness. Some members of the society are apparently able to see a little better than others, and this gives them a slight advantage, although they pretend to be as blind as any other member; and others develop alternative faculties that set them apart from their peers.

Everyone who has some advantage or other, though blind, finds a way to pull a fast one over the others and to maximise their gains, especially when it comes to accessing goods and services whose supply is becoming strained by the affliction that has struck the whole town. (Instructively, at the very beginning, the person who helps to drive the first blind man home steals the blind mans car).

Government responses are understandably confused, seeing as it is a mighty unusual situation and no one knows how to handle it. Patients are herded into quarantines centres, and the conditions there are unbearable, with excrements and dead bodies clogging the corridors.

Rations are erratic and fought over, and those who can cheat to have extra portions have a field day. Soon there are organised gangs grabbing anything they can loot that is destined for those in the detention centres, who cannot get out because troops have been stationed outside the gate with orders to shoot any escapees.

As conditions worsen, all sorts of systems for the exploitation of the weakest members of the cohort come to the fore, with quarantine inmates forced to trade whatever earthly belongings they have, just to stay alive, until they run out of anything they can trade for a little food. Soon, the age-old sexual exploitation of women shows its ugly head.

Its this last act of abuse perpetrated against the women of the community that spurs an uprising led by the females who throw themselves against the hoodlums who have dominated them using the scourge of blindness that has afflicted their community as cover. The women thus become the spearhead of a popular uprising that overthrows the oppressive system.

Saramagos is a frightening story, but one that is easy to recognise in our present realities imposed by the Covid-19 pandemic. The fact that even the most distinguished virologists and epidemiologists have so little knowledge as to how this pandemic will eventually play out, makes us all blind.

As devastating as the pandemic will prove to a great many people around the globe, the smart alecks will try to take advantage of this calamitous situation, and the masses, with their usual credulity, will fall victim to all sorts of schemes and stratagems.

A short while ago I was contemplating the messaging put out to the people in Tanzania. Shall we now all come out and celebrate because we have vanquished the virus? Or, shall we continue taking all the precautionary measures to halt its spread?

In Dar es Salaam, I have witnessed people do the two at the same time, and I have wondered what the double messaging could be in aid of.

The blindness in Saramagos novel need not be the physical unseeing such as our gallant ophthalmologists have to deal with.

Blindness can be bestowed on a peopleor, rather, a people can bestow blindness on itselfwith fully functional biological eyes that have been made to see nothing.

Jenerali Ulimwengu is chairman of Raia Mwema newspaper and an advocate of the High Court in Dar es Salaam. E-mail: [emailprotected]

Read more:
Profiteers on the prowl as mass blindness is loosed upon us all - The East African

Read More...

Why Molly Burke, who accidentally became ‘the blind girl of YouTube,’ doesn’t want her sight back – Insider – INSIDER

June 6th, 2020 7:44 am

Molly Burke turned to YouTube when she lost her sight, and subsequently all her friends, at 14 years old.

Early teenage years are tough for anyone, but getting bullied and going blind on top of the hormones, puberty, and general unease sent Burke to a really dark place where she even considered suicide. It was delving deep into the world of YouTube that helped pull her out and find a new path.

"I somehow ended up stumbling upon the beauty lifestyle community and that kind of became my home on YouTube," she told Insider. "Because I found these girls who were all around my age, either 13, 14, or 15, and they were talking about all the things that I've always loved: makeup, fashion, dating all of these things that at 14 felt so important to me. And honestly, at 26, still feel important to me."

She said it was like having friends again, because these were things teenage girls talk to their friends about when they're going shopping or having sleepovers, which Burke was no longer invited to. Her former friends stopped talking to her when bullies started seeing her as an easy target.

"It kind of filled that gap in my life," she said. "I could no longer look in store windows, read magazines, or swatch lipsticks on the back of my own hand at Sephora. But I could listen to them describe the colors of the lipsticks. I could listen to them talk about what clothes were trendy."

These videos were a way for Burke to get into the world of fashion and makeup again, through listening to her new-found best friends and big sisters.

Burke knew she one day wanted to set up her own channel, but she didn't actually do it until she was 20. She said she always wanted to wait until she was at the tail end of her journey through recovery and self-acceptance rather than the beginning.

Even at 16 she had the wisdom to understand she wasn't ready, because if she set up her channel and received unkind comments they would destroy her. She knew she had to be in a place where she was fully secure with who she was.

To this day Burke gets comments saying she's faking her blindness, or suggesting she's been cured and is just continuing the facade for attention all of which are things people would say to her back when she first lost her sight.

"It's something I faced at 14 and it crushed me because it felt so invalidating to the very real pain I was living with," she said. "But because I started at 20 when I worked so hard to get through that period in my life and get to the other side, by the time I was receiving those comments, I just laughed. It didn't bother me at all. I'm like, 'Oh, look at you with your cute little ignorance.'"

Molly Burke uses criticism to fuel her. Molly Burke / YouTube

One Reddit post Burke finds particularly hilarious is dedicated to a conspiracy about how she used to be blind, but she found the cure and is keeping it to herself.

"It was like, 'She knows too much about blindness to have not at one point been blind, but I think she either found a cure or got better,'" she said. "Like blindness is the common cold that you just recover from, or like I'm harboring the cure in my two-bedroom LA apartment. Like I know the cure for blindness but I'm not going to share it."

Comments doubting Burke's disability have inspired her to highlight topics that the online world needs to know more about, such as why her eyes shake, how she can look at the camera, and why the eyes of blind people don't all look the same.

Burke uses the criticism whether it's made in good faith or is blatant trolling to energize her to make more content to educate people. This was a lesson she learned through going to five different schools and getting bullied each time.

"By the time I was in grade 11 and 12, it was just like, 'Instead of letting it tear me down, I'm gonna let it fuel me up,'" she said. "Let it fuel my fire, raise me up, push me forward."

Once Burke had been on YouTube for a while, she received a comment that has stuck with her until today. The fan said they didn't just want to hear her talk about blindness, they wanted to hear about her life, too.

For Burke it was a relief, because before YouTube she already had a successful career as a motivational speaker. She loved educating people, but for over two years she was booked solid speaking about being blind, being bullied, and mental illness.

"I was starting to feel like things were defining me again," she said. "I wanted to have another creative outlet, another way to continue to entertain and educate like I did as a motivational speaker, but about the things that also make up Molly. The other facets of who I am: the girl who loves fashion and makeup, and dogs, and funny dating stories, and yoga, and tea, and bubble baths, and all of these other things. And so that's why I started the channel."

Burke, and her trusty guide dog Gallop, now have a huge following of nearly two million subscribers. She has collaborated with some of YouTube's biggest stars, including Shane Dawson, Colleen Ballinger, and James Charles. To maximize clickbait in the titles and thumbnails, creators often refer to her as a "blind girl," which Burke has no issue with because it helps her spread awareness.

In one recent video, Burke emotionally told a story that she and Gallop face all too often. She'd reached a breaking point and had to talk about how Uber and Lyft drivers often cancel her rides when they see she has a dog with her.

"It was just a boiling point for me where I was noticing how much it was truly affecting me emotionally and how much it was weighing on me," she said. "I really needed to talk about it because at the end of the day, I do what I do in the hopes of creating change."

Burke explained in the video how one experience was a stark reminder that she isn't always treated equally because of her disability. After starring in a commercial and celebrating with her friends, her day was ruined when the ride she had ordered to get her home drove off upon seeing Gallop.

"My guide dog for me isn't a choice," she said in the video. "Gallop isn't a choice. Gallop is my mobility, he is my freedom, he is my independence. The best way I can explain it is Gallop to me is what a wheelchair is to someone who is paralyzed. It is a need, it is not a want."

Burke told Insider she believes people won't care about a cause until they are given a reason to, because there are so many issues in our world to be passionate about. That usually comes with having a family member or close friend who has a disability.

"I want to be that reason," she said. "I want people to feel connected to me enough to be that real human in their lives that makes them care about this community more and helps them understand that more."

Burke loves what she does because it combines her two passions: performing and educating. But she never intended to become the "blind girl of YouTube."

"I wanted to be one of many blind people, one of many disabled people, because their success doesn't take away from my success," she said. "Their success builds the success of our community, gaining representation and breaking barriers to the rest of society. And that's ultimately what I've always wanted."

Burke said if the blind community had more voices on YouTube, it would take a lot of pressure off her. Being a prominent blind person on YouTube means people often mistakenly think she represents the whole blind community.

"That has come with blind people being my biggest supporters and blind people being my biggest haters," she said. "Because the blind people who feel like I'm representing them love me. But the blind people who don't feel like I represent them dislike me because they don't feel like my content is authentic to them."

Burke's experience is just hers, and it shouldn't be taken as the one and only story there is. That's why she always wants to make it clear in her videos and public speaking that she is not all blind people.

"I'm Molly and Molly is blind," she said. "Don't take my experience as the experience of blindness."

Molly Burke doesn't speak for the entire blind community. Chris Sanders

In one example, Burke decided she was going to get laser hair removal on her legs, but she had never shaved before (which is a requirement before the procedure). Her mother, being an "Irish mama who grew up in the sixties," had never been that bothered about hair removal, so when the time came for Burke to ask her about it, she simply took her daughter to get waxed instead.

Burke thought it would be a fun video to film herself shaving her legs for the first time. She didn't expect the backlash she received.

"All these blind girls were like, 'You are making it seem like blind girls don't know how to take care of themselves, this is ridiculous,'" she said. "I was like, I'm sorry, did you ever hear me say that once in a video? Did you ever hear me say I'm the first blind girl ever to shave? Nope. Never said it."

The expectation to represent all blind people is not one Burke asked for, or something she thinks is fair. It's too much pressure for one person.

"I cannot bear that weight because no matter how hard I try, I can never represent every blind experience," she said, "And that's why I always encourage other blind people to make content and to share their perspective."

Another thing that divides the blind community is wheter or not they want to be cured. Burke grew up in the world of the medical model of disability, which is the belief that a cure for your disease or condition is paramount. Essentially it means seeing disability through the lens of an able-bodied person, and assuming that it must be depressing, inconvenient, and terrible.

She was literally the face of a charity whose sole goal was to find a cure for her disease a breakdown and loss of cells in the retina called Retinitis pigmentosa.

She does not think organizations and charities should stop searching for a cure, but she does want to change the way the world sees and talks about it. She's tired of the fundraisers that describe disabilities like blindness as a devastating, life-ending thing with a young girl who will "never pick her own wedding dress" or "see her family smile" because she "lives in darkness."

"If I'm being told that my whole life and then I go blind and there is no cure for me, how the hell am I supposed to feel about myself?" she said. "Depressed, broken, less than, incomplete? Like I need to be fixed or change in order to be whole, in order to be successful, in order to find love and success in life?"

#wef20

A post shared by Molly Burke (@mollyburkeofficial) on Jan 27, 2020 at 12:37pm PSTJan 27, 2020 at 12:37pm PST

Burke now believes in the social model of disability, which means tackling the misconception that the only option to be successful, happy, and whole as a disabled person is through finding a cure.

"That is absolute garbage," she said. "We as disabled people shouldn't be told that inherently we are less than or our life won't be as good because we are disabled."

The way we talk about a cure has a great impact on how we will live our lives, she said.

"It breaks my heart how many disabled people don't live life, they sit and wait for a cure," she said. "That is no way to live."

Burke went through a long journey of feeling angry, broken, and hopeless to reach where she is now: She does not want to be cured. It took around four years of discussions with her disability mentor, with whom she is still very close, to be open to hearing that her life was enough as it is, and how she would be able to live happily without a cure to her blindness.

Part of that journey was accepting that a cure for Retinitis pigmentosa will probably never be found in her lifetime. Even if there is progress, it will probably a very expensive surgery that results in a slight improvement in shadow and light perception, which Burke has decided she does not want to put herself through. Returning someone's full vision is unlikely to ever be on the cards.

She has accepted that and she feels comfortable, happy, successful, and whole knowing that blindness is just one challenge she faces. If she was cured, all her problems wouldn't be gone. Her focus would just be on a different one.

For example, blind people are less likely to get divorced, which is a statistic Burke loves.

"My friend might get divorced and I might get to live my whole life in a happy marriage," she said. "Divorce is a challenge that they have to cope with. I've learned to deal with my challenges to live with them, to accept them, and to make the most of them. And so I'm not going to change my life in the hopes that I won't have challenges anymore, because that's unrealistic."

When Burke told her parents she no longer wanted her sight back, her mom breathed a sigh of relief and said: "Oh thank God."

"She was so relieved because, as a parent, she had felt so much pressure to help me be my best self," Burke said. "And she had always been taught to think that was through a cure."

She wants more able-bodied parents of disabled children to be open to the idea of the social model of disability because it takes away the pressure of needing to "fix" their child.

"It empowers everyone to just say, 'You know what? We can make damn best of this,'" she said. "We can live our best lives, be happy with the beautiful, wonderful child we do have and empower them to feel beautiful and confident the way they are."

Burke doesn't necessarily think anyone alive right now will live to see the world completely shift to this frame of mind, but she hopes to be at least 0.01% of helping bring that change.

Guide dogs cost between $40,000 and $60,000. Chris Sanders

Burke is currently raising money for the MIRA Foundation through merch sales, which is a charity that provides guide dogs to blind people. The organization is having a really tough time right now, she said, because they are not able to train the dogs (which cost between $40,000 and $60,000) during the coronavirus pandemic and they receive no government funding.

"I'm trying to do my part right now to help my community," she said.

Her job is incredibly stressful and overwhelming at times, but she wouldn't change it for the world. She said even when she's feeling the pressure the most, she refuses to stop or slow down.

"I don't want to because I love this so much," she said. "I can be stressed and overwhelmed and overworked in a job that I hate or I can be stressed, overwhelmed and overworked in a job that I'm so passionate about."

That passion certainly comes through because her followers, both blind and sighted, can always find something to relate to. She said a lot of her content, be it swimwear hauls, hair dye attempts, or storytime videos about first dates, ultimately show her viewers "how normal I am."

"I think if you boil my experiences and story down to one thing that is relatable for everybody is that I've overcome challenges again, and again, and again," she said. "And I will continue to, and I encourage everybody else to do the same."

Read more:

Garrett Watts might be the most unpredictable creator on YouTube, and that's why fans live for his rare uploads

Tana Mongeau's authenticity is the secret to her skyrocketing career, but she'll probably never date anyone in the spotlight again

Beauty superstar Manny MUA says being 'canceled' led to the darkest period of his life. Now he writes his own narrative.

A former 'SNL' assistant turned YouTuber with millions of followers tells all about vlog-life from eating toenails to burnout

The life and controversies of YouTuber Trisha Paytas, from public feuds and breakups to identifying as 'a chicken nugget'

Read more here:
Why Molly Burke, who accidentally became 'the blind girl of YouTube,' doesn't want her sight back - Insider - INSIDER

Read More...

VERIFY: Tear gas is banned from war, but not banned for use by law enforcement internationally – WUSA9.com

June 6th, 2020 7:44 am

Is it legal for police officers to use tear gas on protesters? We break down when the chemical irritant can and can't be used.

For days, people across the nation have marched to protest the killing of George Floyd, a black man who died after a Minneapolis police officer held his knee on Floyds neck.

Police forces have responded to these protests with tear gas and other anti-riot measures. Protesters have posted countless photos and videos to social media showing police firing the chemical gas during the demonstrations.

The most common types of chemicals used in these agents today are chloroacetophenone and 2-chlorobenzalmalononitrile, according to the CDC. Usually, these chemical compounds cause a burning sensation in the eyes, nose and on the skin. Long-lasting exposure or large doses could cause blindness, respiratory failure or death, the CDC says.

Some posts claim tear gas is illegal to use in warfare - so why can police use it against civilians?

So the VERIFY team researched the rules behind tear gas.

THE QUESTION

Is the usage of tear gas a war crime?

THE ANSWER

But law enforcement can still legally use it for riot control purposes. In fact, the same agreement that banned and criminalized tear gas in warfare also specifically allowed for its use by law enforcement.

WHAT WE FOUND

The general use of asphyxiating, poisonous or other gases was prohibited by the Geneva Protocol of 1925, shortly after WWI. The text of the protocol was short and did not specify beyond that what gases were banned.

The United States Senate, according to the State Department, did not ratify the treaty at the time. In fact, the United States continued to use tear gas and chemical herbicides in the Vietnam War, arguing that such chemicals were not covered by the Geneva Protocol. But other countries, especially those in the Soviet bloc, argued that the use of tear gas was prohibited by the Geneva Protocol.

A Swedish ambassador at the time argued there was a danger of escalation if nonlethal chemical agents were permitted but also pointed out that the military use of tear gases should be distinguished from their use for riot control, the State Department says.

A broader interpretation of the Geneva Protocol was then adopted and the United States eventually ratified it -- with a few riot-control exceptions -- in 1975.

In 1992, the United Nations held a convention on chemical weaponscalled the Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on Their Destruction.

During this meeting, the organization developed a second treaty that was similar to the first, but more explicit in its guidance. The updated agreement prohibited members from using "riot control agents as a method of warfare."

That convention explicitly defined riot control gases as chemicals "which can produce rapidly in humans sensory irritation or disabling physical effects which disappear within a short time following termination of exposure," to avoid the debate that occurred following the Geneva Protocol.

But the issue provoked debate among member states. Jamil Dakwar, a representative from the ACLU, said in an interview with PRI said there was pressure to ban chemical weapons in the leadup to the Chemical Weapons Convention. He said many countries argued they would resort to more lethal methods to control their own citizens if law enforcement could not use these chemicals.

So as a compromise, the agreement again allowed an exception for the use of these chemicals for domestic riot control purposes.

Our expert also explained some of the risks involved when using these chemicals during wartime.

Richard Price, a political science professor at the University of British Columbia and the author of The Chemical Weapons Taboo, told VERIFY in an email that soldiers dont have the luxury of determining if gasses shot at them are tear gases or much more lethal chemical weapons like chlorine, mustard or what have you."

He said any gases on the frontlines could expose a country to false accusations of using illegal chemicals. Such claims could escalate the conflict further.

"The best thing to avoid potentially false accusations of prohibited lethal chemical use (that then spirals to more general use in retaliation) was to just ban them all in the context of battle.

He also explained that the Chemical Weapons Convention decided on the term "riot control" gases rather than non-lethal gases because they can kill, if in sufficient dosage and concentration, such as in a confined area, but that is very rare since they are usually used outdoors, but thats one reason why the CWC doesnt differentiate these as lethal/non-lethal gases, but rather define according to the purpose (riot control).

BOTTOM LINE

Yes, tear gas is banned for use in war. However, the same international provisions that ban it also allow law enforcement to use it domestically.

Its also incorrect to say tear gas is non-lethal. It can be lethal in confined areas, which is one reason its banned in war. Its very rarely lethal when used outdoors.

Though many countries use these chemicals for riot control purposes, their use remains controversial.

See more here:
VERIFY: Tear gas is banned from war, but not banned for use by law enforcement internationally - WUSA9.com

Read More...

PHOTOS: The Global South Shows Solidarity For George Floyd : Goats and Soda – NPR

June 6th, 2020 7:44 am

A Maasai man in the Kibera slum of Nairobi, Kenya, prays next to a mural of George Floyd, painted by the artist Allan Mwangi on June 3. Gordwin Odhiambo/AFP via Getty Images hide caption

A Maasai man in the Kibera slum of Nairobi, Kenya, prays next to a mural of George Floyd, painted by the artist Allan Mwangi on June 3.

Around the world, people have held vigils, organized protests and painted murals this week to show solidarity with the Black Lives Matter protests taking place across America.

These events are also taking place in countries struggling with their own crises conflict, poverty, the pandemic. America's loud call for justice after the deaths of George Floyd, Breonna Taylor, Ahmaud Arbery and many more black Americans has resonated.

In Nigeria, a dozen protesters gathered in front of the U.S. embassy in Abuja with signs that said "Black life matters." In Ghana, the president tweeted a drawing of George Floyd and wrote: "Black people, the world over, are distraught by the killing of an unarmed black man."

And in Syria's war-torn city of Idlib, artist Aziz Asmar says he was moved to create a mural after watching the media coverage around Floyd's death.

"I decided to paint George Floyd on the rubble of a building destroyed by aviation ... to send a message to the world that despite the international negligence and blindness of the killing of civilians in Syria over a period of 10 years, we have a humanitarian duty to sympathize with all the oppressed in the world," he wrote to NPR. "Because we are advocates of peace, we hope that racism and crime will disappear and that the world will enjoy happiness."

Here are more examples of how people around the world are honoring black lives and demanding racial equality.

Members of the All India Peace and Solidarity Organization hold placards in silent protest at the U.S. consulate in Hyderabad, India, on June 4. Noah Seelam/AFP via Getty Images hide caption

Palestinian digital artist Munes al-Salihi draws a portrait of George Floyd at his house in a refugee camp in the Gaza Strip on June 4. Mohammed Abed/AFP via Getty Images hide caption

A woman holds a sign saying "Justice for George Floyd" in Spanish in Buenos Aires, Argentina, on June 2. Ronaldo Schemidt/AFP via Getty Images hide caption

A man kneels during a protest against police brutality in Mexico City on June 4. Manuel Velasquez/Getty Images hide caption

The rest is here:
PHOTOS: The Global South Shows Solidarity For George Floyd : Goats and Soda - NPR

Read More...

RIT faculty earns NIH grant to use virtual reality to help stroke patients regain lost vision | College of Science – RIT University News Services

June 6th, 2020 7:44 am

Scientists from Rochester Institute of Technology and the University of Rochester aim to use virtual reality to help restore vision for people with stroke-induced blindness. The team of researchers led by Gabriel Diaz, associate professor at RITs Chester F. Carlson Center for Imaging Science, received a grant from the National Institutes of Health to develop a method they believe could revolutionize rehabilitation for patients with cortically-induced blindness. The condition afflicts about 1% of the population over age 50.

While there are well-established therapies to help stroke patients regain their motor functions, there are no standardized rehabilitation strategies to restore lost vision. Over the past 10 years, Krystel Huxlin, the James V. Aquavella, M.D. Professor in Ophthalmology at URs Flaum Eye Institute, has found that these patients can regain portions of their vision through targeted exercises that force them to use the blind portions of their visual field. Huxlin and Diaz believe virtual reality could be a key to helping this form of treatment take the next step.

The goal of this work is to build upon Dr. Huxlins methodologies in a few ways, said Diaz, the principal investigator of the grant. One major limitation of the current methodology is that people cannot train as effectively at home if theyre not under the supervision of a researcher whos using an eye tracker. Eye trackers are an emerging technology in the field of virtual reality and were going to develop a training apparatus that could be used at home.

Built-in eye trackers in virtual reality headsets will allow patients to ensure they are fixated on the correct spot and doing the exercises properly. Huxlin said that the eye-tracking technology plus cost savings will make the exercises much more effective at home for patients.

We can do it in the lab right now with a desktop and a desktop-mounted eye tracker, but thats a $40,000 device on top of the computer itself, said Huxlin, a consultant on the project, and close collaborator of Diaz. So, its completely impractical to deploy into a patients home. Its too expensive and even if you were able to afford it, its almost impossible to self-calibrate and use the system on yourself. You have to have another person do the calibration on you.

Virtual reality also has the added benefit of making the exercises multisensory, adding audio cues in addition to visual stimuli. Research suggests that the audio and visual systems are interconnected, so the team will see if sound cues can help accelerate visual rehabilitation. Ross Maddox, assistant professor in URs Departments of Biomedical Engineering and Neuroscience, is providing expert consultation in this realm.

Preliminary testing is already underway. Catherine Fromm, an RIT imaging science Ph.D. student, has been conducting research on the virtual reality components in Diazs Perception for Movement (PerForM) Lab. Diaz will also seek out undergraduate students to help modify eye tracking equipment for the project.

For more information, visit the NIH website.

Here is the original post:
RIT faculty earns NIH grant to use virtual reality to help stroke patients regain lost vision | College of Science - RIT University News Services

Read More...

Reflecting on our roots: on Arabs, racism and ignorance – Miscellany News

June 6th, 2020 7:44 am

First and always foremost, rest in peace, George Floyd. May justice for him and for all Black people be swift and unyielding.

Second and less significantly, this is a piece that reflects my experience. It is not, however, a commentary on Black lives, on George Floyds murder or on the systemic oppression that Black individuals must confront each and every day. It is clear to me, and should be clear to all, that those of us who are not Black should not impose our opinions and perspectives on Black issues, Black oppression and the lived experiences of Black people. We need to amplify those marginalized voices and, for once, shut up and listen.

Our two cents are worth nothing when it is not pennies that Black men and women seek; it is freedom.

Now that weve established those realities, there is a real injustice that I felt obliged to speak on. As the key events within the George Floyd murder continued to be revealed, it was reported that the store that Floyd attempted to use a counterfeit bill at was owned and operated by an Arab man, Mahmoud (Mike) Abumayyaleh. As rumors swirled surrounding Abumayyalehs role in the arrival of the police, many Arab-American journalists began calling out not only Abumayyaleh for engaging with the police, but more broadly the realities of racism among the Arab peoplemy people.

It was later revealed that Abumayyaleh was not the one who called the police, but rather one of his employees did. A spokesman for Abumayyaleh emphasized that store protocol mandates employees call the police when counterfeit bills are used. However, it is impossible to excuse his employees behavior as mere obedience. How could he not have understood the tragic realities of calling the police on a Black man in America, that exposing an individual to a life-threatening situation over 20 fake dollars is not just an unfair tradeits deadly.

Abumayyaleh has since spoken out in grief over the murder, explaining that his employees were following protocol and justifiably blaming the four policemen who committed the murder. The store owner made his remorse clear: By simply following procedure we are putting our communities in dangerwe must stand together to fight institutional racism.

Perhaps Abumayyaleh has known of the risks of law enforcement and systemic racism for a long time, or perhaps he discovered this when his employees called him crying, helpless as those murderers in blue slowly sucked the air out of George Floyds windpipe. At some point, Abumayyaleh realized that following state-authorized instructions to police a Black man within a system founded upon shackled and chained Black bodies is not just a bad ideaits deadly.

Conversations surrounding Abumayyaleh extended beyond his shop and began to address some of the ugly racial realities of the Arab world. Many Arabs are anti-Black. Institutionalized racism in the Middle East does not look like its American counterpart, but it exists. This division is ingrained into Arab culture and is one that has seeped into the Arab people.

I did not see this oppression within my own culture for the longest time, though often it existed right in front me. My privilege as a Arab man allowed me to ignore the realities of racial injustice in my own backyard. However, in the fight for Black freedom, I cannot confront American racial injustice while continuing to ignore the grim racist realities of my own home. The fight must start from within.

We are the children of a generation whose name for Black peopleabdliterally means slave. We are the consequences of a government that built the Kafala system, which leaves the legal status of migrant workers in the hands of their employer.

Many white-passing Arabs are conscious of their own racial prejudice toward their darker-skinned counterparts. Theres a reason that the Sudanese revolution of 2018 was, for many Sudanese protesters, an African revolution. Being marginalized for their skin color for decades left those same Sudanese people frustrated at the state of their Arab identity. Sudanese people, in large part due to the color of their skin, have been often pushed aside in the conversation of Arabhood, and treated as second-class citizens among those who even choose to acknowledge the African country at all. So for those Sudanese people who fled their revolting country in search of monetary freedom elsewhere in the Middle East, they were instead met with racial slurs and an economic system that essentially enslaved them.

The outcome then, tragically, for those Black individuals who entered the Middle East was not so different from the stories of Ahmaud Arbery and George Floyd.

Alem Dechesa fled her native Ethiopia to my home country, Lebanon, in search of work as a maid. What she found was not a financial haven, but a hellish reality. Severely beaten, verbally berated and consistently abused for months, Dechesa took her own life. For many Ethiopians, Dechesas suicide was not a surprise. It was the culmination of the tragic realities that they face everydayas was Floyds murder for many Black people.

These are the racial intersections that are still ignored and that still need to be faced by those who so easily turn the other cheek. We have a responsibility as people of minority groups to support the battle for justice. Arabs experience our ownvery differentset of injustices and discriminations within the United States. Yet when we stand, fists raised, without addressing the racism within our own backgrounds, the validity of our support is compromised.

This is not an easy reality to swallow. Accepting that youve stood idle as institutionalized racism decimated Black bodies around you is difficult to accept. Furthermore, coming to terms with your own racialized and prejudiced roots while simultaneously opposing racism outside your home is perhaps an even more difficult epiphany to have. But if justice is your goal, it is necessary. If we intend to uphold the truth behind our protests, our chants, our actions, then we must bring that energy to fight the systems of racism that exist in our homes, and help elevate the Black bodies who suffered on our soil for so long.

An acknowledgement of not only our privilege but our role in the systemic racism in our own homes is perhaps the most necessary personal action a minority protestor can take. Understanding how racism has benefited you and how it has forced you quiet is the first and most significant step in undoing that silence and freeing our Black brothers and sisters.

We are not for change until we return to the places that raised us, and raise that same clenched fist to those roots that remain corrupted and rotten.

Go here to see the original:
Reflecting on our roots: on Arabs, racism and ignorance - Miscellany News

Read More...

Global Stem Cell Therapy Market 2020 Research Report Insights and Analysis, Forecast to 2026 – 3rd Watch News

June 6th, 2020 7:43 am

The Stem Cell Therapy market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Stem Cell Therapy market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porters Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Stem Cell Therapy market.

Download PDF Sample of Stem Cell Therapy Market report @ https://www.arcognizance.com/enquiry-sample/1030514

Major Players in the global Stem Cell Therapy market include:, Holostem Terapie Avanzate, Osiris Therapeutics, NuVasive, BIOTIME, Advanced Cell Technology, Caladrius, Pharmicell, JCR Pharmaceuticals, RTI Surgical, AlloSource, MEDIPOST, Anterogen, BrainStorm Cell Therapeutics

On the basis of types, the Stem Cell Therapy market is primarily split into:, Autologous, Allogeneic

On the basis of applications, the market covers:, Musculoskeletal disorders, Wounds and injuries, Cardiovascular diseases, Surgeries, Gastrointestinal diseases, Other applications

Brief about Stem Cell Therapy Market Report with [emailprotected] https://www.arcognizance.com/report/global-stem-cell-therapy-market-report-2019-competitive-landscape-trends-and-opportunities

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:, United States, Europe (Germany, UK, France, Italy, Spain, Russia, Poland), China, Japan, India , Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam), Central and South America (Brazil, Mexico, Colombia), Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria), Other Regions

Chapter 1 provides an overview of Stem Cell Therapy market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Stem Cell Therapy market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Stem Cell Therapy industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Stem Cell Therapy market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Stem Cell Therapy, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Stem Cell Therapy in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Stem Cell Therapy in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Stem Cell Therapy. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Stem Cell Therapy market, including the global production and revenue forecast, regional forecast. It also foresees the Stem Cell Therapy market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:, Historical Years: 2014-2018, Base Year: 2019, Estimated Year: 2019, Forecast Period: 2019-2026,

Some Point of Table of Content:

Chapter One: Stem Cell Therapy Market Overview

Chapter Two: Global Stem Cell Therapy Market Landscape by Player

Chapter Three: Players Profiles

Chapter Four: Global Stem Cell Therapy Production, Revenue (Value), Price Trend by Type

Chapter Five: Global Stem Cell Therapy Market Analysis by Application

Chapter Six: Global Stem Cell Therapy Production, Consumption, Export, Import by Region (2014-2019)

Chapter Seven: Global Stem Cell Therapy Production, Revenue (Value) by Region (2014-2019)

Chapter Eight: Stem Cell Therapy Manufacturing Analysis

Chapter Nine: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter Ten: Market Dynamics

Chapter Eleven: Global Stem Cell Therapy Market Forecast (2019-2026)

Chapter Twelve: Research Findings and Conclusion

Chapter Thirteen: Appendix continued

List of tablesList of Tables and FiguresFigure Stem Cell Therapy Product PictureTable Global Stem Cell Therapy Production and CAGR (%) Comparison by TypeTable Profile of AutologousTable Profile of AllogeneicTable Stem Cell Therapy Consumption (Sales) Comparison by Application (2014-2026)Table Profile of Musculoskeletal disordersTable Profile of Wounds and injuriesTable Profile of Cardiovascular diseasesTable Profile of SurgeriesTable Profile of Gastrointestinal diseasesTable Profile of Other applicationsFigure Global Stem Cell Therapy Market Size (Value) and CAGR (%) (2014-2026)Figure United States Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Europe Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Germany Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure UK Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure France Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Italy Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Spain Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Russia Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Poland Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure China Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Japan Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure India Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Southeast Asia Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Malaysia Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Singapore Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Philippines Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Indonesia Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Thailand Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Vietnam Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Central and South America Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Brazil Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Mexico Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Colombia Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Middle East and Africa Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Saudi Arabia Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure United Arab Emirates Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Turkey Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Egypt Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure South Africa Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Nigeria Stem Cell Therapy Revenue and Growth Rate (2014-2026)Figure Global Stem Cell Therapy Production Status and Outlook (2014-2026)Table Global Stem Cell Therapy Production by Player (2014-2019)Table Global Stem Cell Therapy Production Share by Player (2014-2019)Figure Global Stem Cell Therapy Production Share by Player in 2018Table Stem Cell Therapy Revenue by Player (2014-2019)Table Stem Cell Therapy Revenue Market Share by Player (2014-2019)Table Stem Cell Therapy Price by Player (2014-2019)Table Stem Cell Therapy Manufacturing Base Distribution and Sales Area by PlayerTable Stem Cell Therapy Product Type by PlayerTable Mergers & Acquisitions, Expansion PlansTable Holostem Terapie Avanzate ProfileTable Holostem Terapie Avanzate Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table Osiris Therapeutics ProfileTable Osiris Therapeutics Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table NuVasive ProfileTable NuVasive Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table BIOTIME ProfileTable BIOTIME Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table Advanced Cell Technology ProfileTable Advanced Cell Technology Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table Caladrius ProfileTable Caladrius Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table Pharmicell ProfileTable Pharmicell Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table JCR Pharmaceuticals ProfileTable JCR Pharmaceuticals Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table RTI Surgical ProfileTable RTI Surgical Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table AlloSource ProfileTable AlloSource Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table MEDIPOST ProfileTable MEDIPOST Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table Anterogen ProfileTable Anterogen Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table BrainStorm Cell Therapeutics ProfileTable BrainStorm Cell Therapeutics Stem Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)Table Global Stem Cell Therapy Production by Type (2014-2019)Table Global Stem Cell Therapy Production Market Share by Type (2014-2019)Figure Global Stem Cell Therapy Production Market Share by Type in 2018Table Global Stem Cell Therapy Revenue by Type (2014-2019)Table Global Stem Cell Therapy Revenue Market Share by Type (2014-2019)Figure Global Stem Cell Therapy Revenue Market Share by Type in 2018Table Stem Cell Therapy Price by Type (2014-2019)Figure Global Stem Cell Therapy Production Growth Rate of Autologous (2014-2019)Figure Global Stem Cell Therapy Production Growth Rate of Allogeneic (2014-2019)Table Global Stem Cell Therapy Consumption by Application (2014-2019)Table Global Stem Cell Therapy Consumption Market Share by Application (2014-2019)Table Global Stem Cell Therapy Consumption of Musculoskeletal disorders (2014-2019)Table Global Stem Cell Therapy Consumption of Wounds and injuries (2014-2019)Table Global Stem Cell Therapy Consumption of Cardiovascular diseases (2014-2019)Table Global Stem Cell Therapy Consumption of Surgeries (2014-2019)Table Global Stem Cell Therapy Consumption of Gastrointestinal diseases (2014-2019)Table Global Stem Cell Therapy Consumption of Other applications (2014-2019)Table Global Stem Cell Therapy Consumption by Region (2014-2019)Table Global Stem Cell Therapy Consumption Market Share by Region (2014-2019)Table United States Stem Cell Therapy Production, Consumption, Export, Import (2014-2019)Table Europe Stem Cell Therapy Production, Consumption, Export, Import (2014-2019)Table China Stem Cell Therapy Production, Consumption, Export, Import (2014-2019)Table Japan Stem Cell Therapy Production, Consumption, Export, Import (2014-2019)Table India Stem Cell Therapy Production, Consumption, Export, Import (2014-2019)Table Southeast Asia Stem Cell Therapy Production, Consumption, Export, Import (2014-2019)Table Central and South America Stem Cell Therapy Production, Consumption, Export, Import (2014-2019)continued

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:Analytical Research Cognizance (ARC)is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARCs potential.ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

Contact Us:Ranjeet DengaleDirector SalesAnalytical Research Cognizance+1 (646) 403-4695, +91 90967 44448Email: [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Read the original here:
Global Stem Cell Therapy Market 2020 Research Report Insights and Analysis, Forecast to 2026 - 3rd Watch News

Read More...

Global Mesenchymal Stem Cells Market Expected to Witness the Highest Growth during 2020-2026 – Jewish Life News

June 6th, 2020 7:43 am

The world isnt just battling a health pandemic yet in addition a economic one, as the Novel Coronavirus (COVID-19) throws its long shadow over economies around the world. The whole lockdown circumstance in a few nations has legitimately or indirectly affected numerous ventures causing a move in activities like gracefully chain operations, seller tasks, product commercialization, and so forth. The Report on Mesenchymal Stem Cells Market which give detailed investigation of impact of the novel Coronavirus (COVID-19) pandemic on the historical and present/future market information.

Ask For Sample Copy of Mesenchymal Stem Cells Report here:https://www.globalmarketers.biz/report/life-sciences/global-mesenchymal-stem-cells-industry-market-research-report/1988#request_sample

GlobalMesenchymal Stem Cells market research reportprovides the latest manufacturing data and business coming trends, providing you to recognize the outcomes and end-users offering Revenue growth and profitability. The Mesenchymal Stem Cells industry report lists the leading competitors and provides the game-changing strategic analysis of the key factors driving the market. The report includes the forecasts by 2026, analysis by 2019, and discussion of significant trade, market volume, market share evaluations and outlines of the top Mesenchymal Stem Cells industry players.

Major Players in Mesenchymal Stem Cells market are:STEMCELL TechnologiesPromoCell GmbHMesoblastAxol BioscienceThermo FisherLonzaMiltenyi BiotecBiological IndustriesBio-TechneIrvine Scientific

Make an Inquiry About This Report @ https://www.globalmarketers.biz/report/life-sciences/global-mesenchymal-stem-cells-industry-market-research-report/1988#inquiry_before_buying

Market Segmentation:

Market Segmentation by Type:

MSC-ATMSC-UCMSC-BMOthers

Market Segmentation by Application:

Cell-based Screening AssaysGene Therapy and TransplantationCell Differentiation and Gene Regulation

Any query? Enquire Here For Discount :https://www.globalmarketers.biz/discount_inquiry/discount/1988

Below is a comprehensive list of the Key Questions to be explained for each element in the Global Mesenchymal Stem Cells Industry, which can help organizations to survive and develop their self. So, here arekey questions answeredin the report to guide the industry.

1. Market size

What is the Mesenchymal Stem Cells industry market size?

And, what will be the market size in the next five years?

2. Global Mesenchymal Stem Cells Market: CAGR

What is the growth rate of the Mesenchymal Stem Cells industry in the next 5 years?

Take a look at

Which segments are growing the fastest?

3. Key Geographies

The biggest contributor to Mesenchymal Stem Cells industry?

Find amongNorth America, Asia-Pacific, Europe, Africa, South America.

Which countries to watch out for the coming years?

Find amongU.S., Canada, U.K., France, Germany, China, India, Russia, The Middle Eastand so on.

4. Market Opportunities

Which factors are contributing to the positive growth of the market?

Applications in

What factors are proving to be opportunities for the Mesenchymal Stem Cells industry?

Want to customize this report? Enquire Here (To get higher priority use company email ID)

5. Key Vendors

Who are the major players in the Mesenchymal Stem Cells business?

What growth strategies are major giantsadopting?

Also, what share do they control?

What developments have they undertaken?

6. Business Challenges

Which factors are contributing to the negative growth of the market?

What factors are proving to be hurdles for the Global Mesenchymal Stem Cells market?

Why buy from us

Custom research service:

Speak to the Mesenchymal Stem Cells report authors to design a premium study to complete your analysis needs.

Quality assurance:

Information security:

Your personal and confidential information is safe and secure with us.

Do you know?

Our library has thousands of reports on hundreds of topics.

Thousands of people come to us for insights every month

Request for more detailed information (TOC and Sample): https://www.globalmarketers.biz/report/life-sciences/global-mesenchymal-stem-cells-industry-market-research-report/1988#table_of_contents

Follow this link:
Global Mesenchymal Stem Cells Market Expected to Witness the Highest Growth during 2020-2026 - Jewish Life News

Read More...

Human Embryonic Stem Cell Market to Witness a Ravishing Growth with International Players BD, Takara Bio Inc., Geron, Thermo Fisher Scientific Inc.,…

June 6th, 2020 7:43 am

The Human Embryonic Stem Cell Market research added by the insight partners, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.

What is Human Embryonic Stem Cell?

The human embryonic stem cells are obtained from the undifferentiated inner mass cell of the human embryo and human fetal tissue. The human embryonic stem cell can replicate indefinitely and produce non-regenerative tissue such as myocardial and neural cells. This potential of human embryonic stem cell allows them to provide an unlimited amount of tissue for transplantation therapies to treat a wide range of degenerative diseases. Hence, human embryonic stem cells are used in the treatment of various diseases such as Alzheimers disease, cancer, blood and genetic disorders related to the immune system and others.

Get Sample PDF Of Human Embryonic Stem Cell Market @https://www.theinsightpartners.com/sample/TIPRE00005165/

Major Players Included in this report are as follows:1. BD2. Takara Bio Inc.3. Geron4. Thermo Fisher Scientific Inc.5. ViaCyte, Inc.6. R&D Systems, Inc.7. QIAGEN8. CellGenix GmbH9. Vitrolife10. Lonza

The global human embryonic stem cell market is expected to grow in upcoming years, factors driving the growth of market are rise in incidences of neurological disorders, increase in investment by government and other organization for research activities, awareness among people about stem cell therapeutic potency for disease treatment. On the other hand emerging stem cell banking services is expected to offer lucrative opportunities in growth of human embryonic stem cell market.

Segmentation Analysis:

The global human embryonic stem cell market is segmented on the basis of product type, application and end user. Based on product type, the market is segmented as totipotent stem cell, pluripotent stem cell and unipotent stem cell. On the basis of application, the global human embryonic stem cell market is segmented into regenerative medicine, stem cell biology research, tissue engineering and toxicology testing. Based on end users, the market is segmented as therapeutics companies, cell & tissue banks, tools & reagents companies and others.

Human Embryonic Stem Cell Market: Regional analysis includes:

o Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)o Europe(Turkey, Germany, Russia UK, Italy, France, etc.)o North America(the United States, Mexico, and Canada.)o South America(Brazil etc.)o The Middle East and Africa(GCC Countries and Egypt.)

Human Embryonic Stem Cell Market: Competitive Landscape-

Analysts have thoroughly evaluated the competitive landscape in the Human Embryonic Stem Cell Market. The report includes the study of key players in the Human Embryonic Stem Cell Market. It also outlines the strategic initiatives companies have taken in recent years to keep pace with increasing competition. It also includes an assessment of the financial perspectives of these companies, their research and development plans, and their future business strategies.

Chapter Details of Human Embryonic Stem Cell Market:

1. Introduction2. Human Embryonic Stem Cell Market Key Takeaways3. Research Methodology4. Human Embryonic Stem Cell- Market Landscape5. Global Human Embryonic Stem Cell Market Key Industry Dynamics6. Human Embryonic Stem Cell Market Global Analysis7. Human Embryonic Stem Cell Market Revenue And Forecasts To 2027 Product Type8. Human Embryonic Stem Cell Market Revenue And Forecasts To 2027 Application9. Human Embryonic Stem Cell Market Revenue And Forecasts To 2027 End User10. Human Embryonic Stem Cell Market Revenue And Forecasts To 2027 Geographical Analysis

11. Human Embryonic Stem Cell Market Analysis And Forecasts To 2027 Industry Landscape12. Human Embryonic Stem Cell Market-Key Company Profiles13. Appendix

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Read More About This Report Athttps://www.theinsightpartners.com/buy/TIPRE00005165/

Report Focus:

Extensive product offeringsCustomer research servicesRobust research methodologyComprehensive reportsLatest technological developmentsValue chain analysisPotential Cosmeceuticals Market opportunitiesGrowth dynamicsQuality assurancePost-sales supportRegular report updates

Key Questions Answered:

o How big will the market for Human Embryonic Stem Cell be in 2027?o What is the current CAGR of the Human Embryonic Stem Cell Market?o Which product is expected to have the highest market growth?o Which application should be used to win a large part of the market for Human Embryonic Stem Cell ?o Which region is likely to offer the most opportunities on the Human Embryonic Stem Cell Market?o Will the market competition change in the forecast period?o Who are the main players currently active in the global Human Embryonic Stem Cell Market?o How will the market situation change within the coming years?o What are the usual commercial tactics for players?o What is the growth perspective of the global Human Embryonic Stem Cell Market?

About us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact us: Call: +1-646-491-9876Email: [emailprotected]

The rest is here:
Human Embryonic Stem Cell Market to Witness a Ravishing Growth with International Players BD, Takara Bio Inc., Geron, Thermo Fisher Scientific Inc.,...

Read More...

Vector-based Systems will Remain Dominant, Accounting for 60% of the Global CRISPR-Cas Genes Market Value – The Cloud Tribune

June 6th, 2020 7:43 am

Fact.MR has adopted a multi-disciplinary approach to shed light on the evolution of the global CRISPR and Cas Genes market during the historical period of 2015 2019. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2020, and key prospects over the forecast period 2020 2026.The CRISPR and Cas Genes market study includes a thorough analysis of the overall competitive landscape and the company profiles of leading market players involved in the global CRISPR and Cas Genes market. Further, the presented study offers accurate insights pertaining to the different segments of the Global CRISPR and Cas Genes market such as the market share, value, revenue, and how each segment is expected to fair post the COVID-19 pandemic.

The global CRISPR and Cas genes market shows stellar future growth prospects, expanding at a CAGR of 21.2% during the forecast period (2020-2026). Extensive rounds of primary and comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the CRISPR and Cas Genes market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in theCRISPR and Cas Genes market.

After reading the CRISPR and Cas Genes market report, readers get insight into:

Request for Sample Report with Statistical Info @https://www.factmr.com/connectus/sample?flag=S&rep_id=4823

The CRISPR and Cas Genes market report offers an assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period. Key regions covered comprise:

The evaluation of the competitive landscape in the CRISPR and Cas Genes market covers the profile of the following top players:

To expand the understanding of opportunities in the global CRISPR and Cas Genes market report looks at close quarters into the opportunities and new avenues in the following key segments:

In addition to understanding the demand patterns of various end user, the report on the CRISPR and Cas Genes market also enumerates trends expected to attract investments by other various associated industries.

On the basis of Product types, the CRISPR and Cas Genes market report offers insight into major adoption trends for the following segments:

By Application,

The global CRISPR and Cas Genes market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In the coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.

For More Detailed Information about Methodology @https://www.factmr.com/connectus/sample?flag=RM&rep_id=4823

Some important questions that the CRISPR and Cas Genes market report tries to answer exhaustively are:

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; thats why we publish multi-industry global, regional, and country-specific research reports.

Media Release:https://www.factmr.com/media-release/1591/global-crispr-and-cas-genes-market

Original post:
Vector-based Systems will Remain Dominant, Accounting for 60% of the Global CRISPR-Cas Genes Market Value - The Cloud Tribune

Read More...

Biotechnology – an overview | ScienceDirect Topics

June 4th, 2020 11:47 pm

1.5 Present and future trends in biotechnology

During the twentieth century humankind has harnessed microorganisms to produce useful biochemical including antibiotics, vitamins, amino acids, flavors and colors, as well as specific proteins (Carlier 2001). Some of these proteins have important medical uses such as insulin, human growth hormone and blood factors like erythropoietin. In fact, manufacturers have developed a series of proven, safe, microbial hosts for use in the production of several enzymes (Warke and Chandratre 2003). Further, enzymes that have not been readily available in adequate quantity can be produced using technology. This in turn has opened up important applications beneficial to humankind. Additionally, modern techniques are leading to the development of tailored enzymes with optimized functional properties specific for their intended use. An example of this is the modification in specific proteases so that they work more efficiently in the alkaline environment of detergent formulations. As a result, less of the modified protease is needed to deliver equivalent cleaning power, while using fewer resources during the manufacturing process.

The microbial cell, a bacterium, yeast, or mold, is the key instrument in many enzyme production processes. To optimize the microbial strains for production of the desired enzyme, the strains genetic properties are often modified either through natural evolution or through classical breeding and selection techniques; these classical techniques have been used for decades to improve microbial production strains. The precise methods of genetic modification have been developed. The methods, sometimes termed genetic engineering, are based on processes occurring in nature - the transfer of genes between different cells.

Scientists to transfer genetic material between cells from the same or different species, microorganisms such as yeasts, molds and bacteria with new or improved properties for industrial applications can be developed. In nature, genetic modification has been occurring since life began. Such genetic changes are generally random, with a natural selection process favoring the changes best adapted for survival. Using this process, animal, plant and microbial breeders have likewise selected individuals within a species with desired characteristics for further propagation.

Using the tools of modern biotechnology, modifications can now be made more precisely and with much less chance of developing unwanted secondary changes that could potentially have undesired effects. In nature and in our production systems, microbes do not express only single enzymes. Rather, each microbial cell has the genetic nature to produce many different enzymes. Frequently, only one of these enzyme activities is needed for a specific application and the side activities are removed or substantially reduced during the recovery process. Often, these side activities are unwanted and may even be detrimental to the final use. Additionally, scientists are now able to discover and/or evolve enzymes that will catalyze pure compounds for applications including textile wet processing such as enzymatic desizing with alpha amylase, bioscouring with pectinase, protease, lipase and cellulase enzymes, binary and mixed enzymatic system, and biopolishing with cellulase enzymes, lipase enzyme for improving hydrophilic nature of polyester fibre both greatly reducing unwanted byproduct production as well as making the target product potentially safer and more effective (Buschie-Diller et al 1994).

Modern biotechnology is one tool that can help meet the challenge this growth poses and also contributed to (a) ecofriendly environment (b) safety and health, (c) reduced water demand in manufacturing processes, (e) reduced industrial waste and (f) aided in pollution remediation. Enzymes produced using modern biotechnology contributes to this effort by assuring the availability of safe, pure enzymes that replace harsh chemical processes (reducing energy consumption and environmental burden). Modern tools of biotechnology, enzymes from nature can be accessed which are sufficiently robust to be useful at extremes of pH and temperature and thus hold great promise for replacing certain chemical processes with much cleaner protein-catalyzed processes (Gubitz and Cavaco-Paulo 2001). Just as exciting, these new enzymes can make the dream of converting waste biomass to useful energy an economic reality. Overall, the use of modern biotechnology for enzyme production can have a major impact on improving the cost and quality of products at the same time working towards sustainability.

Enzymes have applications in many fields, including organic synthesis, clinical analysis, textile processes, and finishing, pharmaceuticals, detergents, food production and fermentation. The application of enzymes to organic synthesis is currently attracting more and more attention. The discovery of new microbial enzymes through extensive and persistent screening will open new, simple routes for synthetic processes and consequently, new ways to solve environmental problems (Calafell et al 2005).

Research on enzyme systems for textile processing and finishing has mainly focused on amylases and cellulases. However, recent biotechnology and genetic engineering advances have opened opportunities for successful applications of other enzyme systems, such as lipases, xylanases, laccases, proteases and pectinases (Emilla Csiszar et al 1998). Today, enzymes can be customized for specific target areas; for example, enzymatic degumming of silk, bioscouring of cotton textiles and antifelting and softening of wool. The basic mechanisms involving enzyme systems and interactions with textile substrates are likely noticed. Using several enzyme systems and application conditions, few researchers are being involved in studying the fibre/enzyme interactions and the compatibility of enzymes in combination (Gisela Buschle-Diller, and S. Haig Zeronian 1998).

Biotechnology offers an increasing potential for the production of goods to meet various human needs. In enzyme technology, a subfield of biotechnology, new processes have been and are being developed to manufacture both bulk and high value added products utilizing enzymes as biocatalysts (Tzanko et al 2002). Enzymes are also used to provide services, as in washing and environmental processes, or for analytical and diagnostic purposes. The driving force in the development of enzyme technology, both in academia and industry, has been and will continue to be:

The development of new and better products, processes and services to meet these needs; and/or

The improvement of processes to produce existing products from new raw materials as biomass.

Enzymes from nature can be accessed which are sufficiently robust to be useful at extremes of pH and temperature and thus hold great promise for replacing certain chemical processes with much cleaner protein-catalyzed processes (Csiszar et al 2001). These new enzymes can make the dream of converting waste biomass to useful energy an economic reality. Overall, the use of modern biotechnology for enzyme production can have a major impact on improving the cost and quality of products at the same time working towards sustainability.

Read the original:
Biotechnology - an overview | ScienceDirect Topics

Read More...

RIT Rallies: Biotechnology alumnus helping Bolivia respond to COVID-19 pandemic | College of Science – RIT University News Services

June 4th, 2020 11:47 pm

An RIT alumnus is helping to lead Bolivias response to the COVID-19 pandemic.

Mohammed Mostajo-Radji 11 (biotechnology) was appointed as Bolivias first ambassador for science, technology and innovation in February. He is typically based out of Silicon Valley, helping to encourage technology investment in Bolivia and facilitating exchanges between universities, technology companies, startups, and more.

But on March 19 he flew back home at the request of Bolivias interim president, Jeanine ez, to help coordinate his countrys efforts to combat COVID-19s spread. His country faces many challenges in fighting the virus, including one of the worlds worst healthcare systems and a unique geographic predicament.

Our countrys high altitude is by far our biggest challenge right now because most of the ventilators dont work appropriately at this level, said Mostajo-Radji. We have large populations living at altitudes above 13,000 feet and most ventilators are made and tested at sea level. In the current market its already extremely difficult to get a ventilator, but maybe only 30 percent of them actually work here.

But he is uniquely equipped to handle the rigors of the job. While at RIT, Mostajo-Radji developed an interest in science diplomacy, minoring in science, technology and society. For his senior thesis, he conducted experiments using Real-time polymerase chain reaction, the same equipment that is now commonly used to test for COVID-19. As he travels around Bolivia helping to set up testing labs, his experience with the equipment allows him to test a few samples to ensure everything is working properly.

After earning his degree at RIT, he went on to earn his Ph.D. in cellular and molecular biology at Harvard University in 2017 and is currently also a postdoctoral scholar in regeneration medicine at University of California, San Francisco.

Mostajo-Radji said he is proud to serve in this capacity and enjoys the work, but when looking back he is shocked at how quickly everything has escalated.

If you had asked me six months ago if I would have been doing this, I would have laughed, he said.

Read the original:
RIT Rallies: Biotechnology alumnus helping Bolivia respond to COVID-19 pandemic | College of Science - RIT University News Services

Read More...

4 Biotechnology Stocks I’m Buying on Weakness – RealMoney – TheStreet

June 4th, 2020 11:47 pm

The S&P 500 is hitting its low point of the day as the FAANG names have reversed lower and breadth runs negative. There isn't any major rush for the exits but the momentum is more concentrated on some of the "economic reopening" plays such as the airlines and Boeing (BA) . Small-cap speculation has slowed and the Russell 2000 ETF (IWM) is struggling.

It isn't just the bears that would welcome a pullback in this market, many bulls would like some better entry points and weakness to buy. Chasing stocks higher day after day grows tiresome when you still have idle cash to put to work. Trying to stay in tune with a market that seems to be acting without regard to the news flow so often is quite exhausting.

While I'm not anticipating any major market pullback, I am looking for some signs that we may have some brief corrective action. At the top of my list is an intraday reversal and a poor close. We have the intraday reversal Thursday but it is fairly mild and we have to wait to see if there is any acceleration of selling into the close.

Even with that sort of action, it is going to be tough for the bears to gain downside traction, especially since bad news doesn't seem to produce any negative response. We have a long list of negative developments to explain some downside action but we just haven't had any come to fruition.

One the strategies I'm developing right now is to slowly start to build some longer term positions in a few biotechnology names as the pullback developes. This remains one of my favorite groups as it is relatively insulated from the ongoing coronavirus sector.

Four biotechnology names I'm looking to buy on weakness are Personalis (PSNL) , Ocular Therapeutix (OCUL) , Aurinia Pharmaceuticals (AUPH) (one of my stock picks for 2020) and Baduax Bio (BXRX) .

I don't see any rush to load up on these names but I'll be watching to make some smaller buys as the market action develops.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

See the article here:
4 Biotechnology Stocks I'm Buying on Weakness - RealMoney - TheStreet

Read More...

AgeX Therapeutics and ImStem Biotechnology Sign Non-Binding Letter of Intent Regarding Investigational MSC Candidate IMS001 for COVID-19 and Other…

June 4th, 2020 11:47 pm

ALAMEDA, Calif. & FARMINGTON, Conn.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (AgeX: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, and ImStem Biotechnology, Inc., a biopharmaceutical company developing human embryonic stem cell-derived mesenchymal stem cells (hES-MSC), today announced their signing of a non-binding letter of intent for ImStem to obtain from AgeX a non-exclusive license to use AgeXs embryonic stem cell line ESI 053 to derive ImStems investigational MSC product IMS001 for development in COVID-19 as well as acute respiratory distress syndrome (ARDS) due to other causes. AgeX and ImStem are co-operating to finalize financial terms and other provisions of a license agreement.

ImStem has previously used AgeX ESI 053 to derive the ImStem IMS001 product which is being investigated for multiple sclerosis under an IND. Earlier this year, the U.S. Food and Drug Administration (FDA) cleared IMS001 to begin a Phase 1 clinical study in patients with multiple sclerosis, after a clinical hold on its Investigational New Drug (IND) application was removed. This is believed to be the first MSC product derived from human embryonic stem cells to be accepted for a clinical trial by the FDA. AgeX and ImStem already have a commercial license in place, which grants ImStem rights to use AgeXs ESI 053 to derive IMS001 as a product candidate for development in autoimmune disease, including multiple sclerosis.

To date, in patients with pneumonia and ARDS due to COVID-19, preliminary literature suggests MSCs, such as ImStems hES-MSC candidate IMS001, may warrant further development consideration. An early clinical study conducted in China by an unrelated group with a different MSC product, Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia, and published in Aging and Disease (2020, Vol. 11, No. 2, pp. 216-228) showed that an intravenous infusion of a different MSC product appeared safe and improved functional outcomes in seven treated patients with COVID-19 pneumonia. MSCs are well recognized to be immunomodulatory in nature, possessing immunosuppressive and anti-inflammatory properties.

Even before their application to COVID-19, MSCs were being investigated as a potential therapeutic option in ARDS, and emerging data in preclinical models has been encouraging. ARDS remains an area of considerable unmet medical need, affecting around 200,000 patients annually in the U.S., accounting for 10% of all intensive care unit patients, and having a mortality of approximately 40%. At the present time, no specific direct therapies exist for ARDS and only supportive treatment is available.

We feel privileged to be part of a global effort to combat COVID-19. This is a unique opportunity for AgeX to leverage its resources to help with the public health challenge at hand. Decades of pioneering work with human embryonic stem cells means this technology is now at a point where it may play a role in the development of a cell-based approach to combating COVID-19. We are very excited by the prospect of expanding our relationship with ImStem to include COVID-19 and ARDS, said Dr. Nafees Malik, Chief Operating Officer of AgeX.

We welcome the opportunity to continue to collaborate with AgeX and explore future development of our IMS001 product in COVID-19 and ARDS from other causes, commented Richard Kim, M.D., Chief Medical Officer of ImStem Biotechnology.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. AgeXs PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeXs core product pipeline is intended to extend human healthspan. AgeX is seeking opportunities to establish licensing and collaboration arrangements around its broad IP estate and proprietary technology platforms and therapy product candidates.

For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

About ImStem Biotechnology

ImStem Biotechnology, Inc. is aspiring to revolutionize how serious diseases with significant unmet needs are treated with a new generation of regenerative and cellular therapies. Pioneering research by its current founder and Chief Technology Officer Dr. Xiaofang Wang and Dr. Ren-He Xu, former director of UConn Stem Cell Institute, led to the proprietary state-of-the-art pluripotent stem cell technology, enabling off-the-shelf, allogeneic stem cell-derived products to be manufactured in scale, differentiating itself from the typical challenges imposed by autologous adult cell therapy products. The company's mission is to advance the science and understanding of human pluripotent stem cell based regenerative cellular therapies through novel and creative development pathways and to fulfill unmet medical needs in serious diseases. And its development strategy focuses on neurologic, autoimmune, degenerative, and rare orphan diseases. ImStem Biotechnology Inc. is a privately held company headquartered in Farmington, CT.

For more information, visit http://www.imstem.com.

Forward-Looking Statements for AgeX

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the Risk Factors section of AgeXs most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. In addition, with respect to AgeXs letter of intent with ImStem there is no assurance that (i) AgeX and ImStem will successfully conclude negotiations and enter into a license agreement; (ii) ImStem will be successful in developing any therapeutic products from a stem cell line licensed by AgeX or that any therapeutic product that may be developed will receive FDA or foreign regulatory approval, or (iii) AgeX will derive revenue or other financial benefits from any license agreement that might be signed with ImStem. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Link:
AgeX Therapeutics and ImStem Biotechnology Sign Non-Binding Letter of Intent Regarding Investigational MSC Candidate IMS001 for COVID-19 and Other...

Read More...

Page 516«..1020..515516517518..530540..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick